Enoxacin for Amyotrophic Lateral Sclerosis (ALS)

NCT04840823 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DRUG: Enoxacin
DRUG: Placebo

Sponsor

McGill University

Collaborators

[object Object]
[object Object]